Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Anticancer drug, also called antineoplastic drug, any drug that is effective in the treatment of malignant, or cancerous, disease. There are several major classes of anticancer drugs; these include alkylating agents, antimetabolites, natural products, and hormones.
China and India are expected to offer good opportunities an account of improvement in healthcare infrastructure. In Africa, industry is expected to drive at lower rate on account of lack of healthcare infrastructure, expensive medical services and lack of consumer awareness.Central & South America is expected to drive at stable rates on account of costly medicines coupled with minimal awareness initiatives by regional government. Global market is also expected to have legal conflicts arising on account of patents which in turn are expected to negatively impact overall industry.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Anti-cancer Drug market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Anti-cancer Drug market. Detailed analysis of key players, along with key growth strategies adopted by Anti-cancer Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Ariad Pharmaceuticals
GlaxoSmithKline
Amgen
Novartis
Celgene Corporation
Merck
Hoffmann-La Roche Ltd
Teva Pharmaceuticals
Bristol-Myers Squibb
Eli Lilly
Bayer
Pfizer
AstraZeneca
Sanofi
Boehringer Ingelheim GmbH
By Type:
Avastin
Rituxan
Herceptin
Alimta
By End-User:
Hospital
Clinic
Home Care
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Anti-cancer Drug Market
-
1.3 Market Segment by Type
-
1.3.1 USA Anti-cancer Drug Market Size and Growth Rate of Avastin from 2016 to 2027
-
1.3.2 USA Anti-cancer Drug Market Size and Growth Rate of Rituxan from 2016 to 2027
-
1.3.3 USA Anti-cancer Drug Market Size and Growth Rate of Herceptin from 2016 to 2027
-
1.3.4 USA Anti-cancer Drug Market Size and Growth Rate of Alimta from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Anti-cancer Drug Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 USA Anti-cancer Drug Market Size and Growth Rate of Clinic from 2016 to 2027
-
1.4.3 USA Anti-cancer Drug Market Size and Growth Rate of Home Care from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Anti-cancer Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Anti-cancer Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Anti-cancer Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Anti-cancer Drug Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Anti-cancer Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Anti-cancer Drug by Major Types
-
3.4.1 Market Size and Growth Rate of Avastin
-
3.4.2 Market Size and Growth Rate of Rituxan
-
3.4.3 Market Size and Growth Rate of Herceptin
-
3.4.4 Market Size and Growth Rate of Alimta
4 Segmentation of Anti-cancer Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Anti-cancer Drug by Major End-Users
-
4.4.1 Market Size and Growth Rate of Anti-cancer Drug in Hospital
-
4.4.2 Market Size and Growth Rate of Anti-cancer Drug in Clinic
-
4.4.3 Market Size and Growth Rate of Anti-cancer Drug in Home Care
5 Market Analysis by Regions
-
5.1 USA Anti-cancer Drug Production Analysis by Regions
-
5.2 USA Anti-cancer Drug Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Anti-cancer Drug Landscape Analysis
-
6.1 West USA Anti-cancer Drug Landscape Analysis by Major Types
-
6.2 West USA Anti-cancer Drug Landscape Analysis by Major End-Users
7 South USA Anti-cancer Drug Landscape Analysis
-
7.1 South USA Anti-cancer Drug Landscape Analysis by Major Types
-
7.2 South USA Anti-cancer Drug Landscape Analysis by Major End-Users
8 Middle West USA Anti-cancer Drug Landscape Analysis
-
8.1 Middle West USA Anti-cancer Drug Landscape Analysis by Major Types
-
8.2 Middle West USA Anti-cancer Drug Landscape Analysis by Major End-Users
9 Northeast USA Anti-cancer Drug Landscape Analysis
-
9.1 Northeast USA Anti-cancer Drug Landscape Analysis by Major Types
-
9.2 Northeast USA Anti-cancer Drug Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Ariad Pharmaceuticals
-
10.1.1 Ariad Pharmaceuticals Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 GlaxoSmithKline
-
10.2.1 GlaxoSmithKline Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Amgen
-
10.3.1 Amgen Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Novartis
-
10.4.1 Novartis Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Celgene Corporation
-
10.5.1 Celgene Corporation Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Merck
-
10.6.1 Merck Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Hoffmann-La Roche Ltd
-
10.7.1 Hoffmann-La Roche Ltd Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Teva Pharmaceuticals
-
10.8.1 Teva Pharmaceuticals Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Bristol-Myers Squibb
-
10.9.1 Bristol-Myers Squibb Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Eli Lilly
-
10.10.1 Eli Lilly Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Bayer
-
10.11.1 Bayer Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Pfizer
-
10.12.1 Pfizer Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 AstraZeneca
-
10.13.1 AstraZeneca Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
-
10.14 Sanofi
-
10.14.1 Sanofi Company Profile and Recent Development
-
10.14.2 Market Performance
-
10.14.3 Product and Service Introduction
-
10.15 Boehringer Ingelheim GmbH
-
10.15.1 Boehringer Ingelheim GmbH Company Profile and Recent Development
-
10.15.2 Market Performance
-
10.15.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Anti-cancer Drug Market Size and Growth Rate of Avastin from 2016 to 2027
-
Figure USA Anti-cancer Drug Market Size and Growth Rate of Rituxan from 2016 to 2027
-
Figure USA Anti-cancer Drug Market Size and Growth Rate of Herceptin from 2016 to 2027
-
Figure USA Anti-cancer Drug Market Size and Growth Rate of Alimta from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Anti-cancer Drug Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure USA Anti-cancer Drug Market Size and Growth Rate of Clinic from 2016 to 2027
-
Figure USA Anti-cancer Drug Market Size and Growth Rate of Home Care from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Anti-cancer Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Anti-cancer Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Anti-cancer Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Anti-cancer Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Anti-cancer Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Anti-cancer Drug
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Anti-cancer Drug by Different Types from 2016 to 2027
-
Table Consumption Share of Anti-cancer Drug by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Avastin
-
Figure Market Size and Growth Rate of Rituxan
-
Figure Market Size and Growth Rate of Herceptin
-
Figure Market Size and Growth Rate of Alimta
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Anti-cancer Drug by Different End-Users from 2016 to 2027
-
Table Consumption Share of Anti-cancer Drug by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Clinic
-
Figure Market Size and Growth Rate of Home Care
-
Table USA Anti-cancer Drug Production by Regions
-
Table USA Anti-cancer Drug Production Share by Regions
-
Figure USA Anti-cancer Drug Production Share by Regions in 2016
-
Figure USA Anti-cancer Drug Production Share by Regions in 2021
-
Figure USA Anti-cancer Drug Production Share by Regions in 2027
-
Table USA Anti-cancer Drug Consumption by Regions
-
Table USA Anti-cancer Drug Consumption Share by Regions
-
Figure USA Anti-cancer Drug Consumption Share by Regions in 2016
-
Figure USA Anti-cancer Drug Consumption Share by Regions in 2021
-
Figure USA Anti-cancer Drug Consumption Share by Regions in 2027
-
Table West USA Anti-cancer Drug Consumption by Types from 2016 to 2027
-
Table West USA Anti-cancer Drug Consumption Share by Types from 2016 to 2027
-
Figure West USA Anti-cancer Drug Consumption Share by Types in 2016
-
Figure West USA Anti-cancer Drug Consumption Share by Types in 2021
-
Figure West USA Anti-cancer Drug Consumption Share by Types in 2027
-
Table West USA Anti-cancer Drug Consumption by End-Users from 2016 to 2027
-
Table West USA Anti-cancer Drug Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Anti-cancer Drug Consumption Share by End-Users in 2016
-
Figure West USA Anti-cancer Drug Consumption Share by End-Users in 2021
-
Figure West USA Anti-cancer Drug Consumption Share by End-Users in 2027
-
Table South USA Anti-cancer Drug Consumption by Types from 2016 to 2027
-
Table South USA Anti-cancer Drug Consumption Share by Types from 2016 to 2027
-
Figure South USA Anti-cancer Drug Consumption Share by Types in 2016
-
Figure South USA Anti-cancer Drug Consumption Share by Types in 2021
-
Figure South USA Anti-cancer Drug Consumption Share by Types in 2027
-
Table South USA Anti-cancer Drug Consumption by End-Users from 2016 to 2027
-
Table South USA Anti-cancer Drug Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Anti-cancer Drug Consumption Share by End-Users in 2016
-
Figure South USA Anti-cancer Drug Consumption Share by End-Users in 2021
-
Figure South USA Anti-cancer Drug Consumption Share by End-Users in 2027
-
Table Middle West USA Anti-cancer Drug Consumption by Types from 2016 to 2027
-
Table Middle West USA Anti-cancer Drug Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Anti-cancer Drug Consumption Share by Types in 2016
-
Figure Middle West USA Anti-cancer Drug Consumption Share by Types in 2021
-
Figure Middle West USA Anti-cancer Drug Consumption Share by Types in 2027
-
Table Middle West USA Anti-cancer Drug Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Anti-cancer Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Anti-cancer Drug Consumption Share by End-Users in 2016
-
Figure Middle West USA Anti-cancer Drug Consumption Share by End-Users in 2021
-
Figure Middle West USA Anti-cancer Drug Consumption Share by End-Users in 2027
-
Table Northeast USA Anti-cancer Drug Consumption by Types from 2016 to 2027
-
Table Northeast USA Anti-cancer Drug Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Anti-cancer Drug Consumption Share by Types in 2016
-
Figure Northeast USA Anti-cancer Drug Consumption Share by Types in 2021
-
Figure Northeast USA Anti-cancer Drug Consumption Share by Types in 2027
-
Table Northeast USA Anti-cancer Drug Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Anti-cancer Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Anti-cancer Drug Consumption Share by End-Users in 2016
-
Figure Northeast USA Anti-cancer Drug Consumption Share by End-Users in 2021
-
Figure Northeast USA Anti-cancer Drug Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Ariad Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ariad Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Ariad Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Ariad Pharmaceuticals
-
Table Product and Service Introduction of Ariad Pharmaceuticals
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Celgene Corporation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation
-
Figure Sales and Growth Rate Analysis of Celgene Corporation
-
Figure Revenue and Market Share Analysis of Celgene Corporation
-
Table Product and Service Introduction of Celgene Corporation
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Hoffmann-La Roche Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hoffmann-La Roche Ltd
-
Figure Sales and Growth Rate Analysis of Hoffmann-La Roche Ltd
-
Figure Revenue and Market Share Analysis of Hoffmann-La Roche Ltd
-
Table Product and Service Introduction of Hoffmann-La Roche Ltd
-
Table Company Profile and Development Status of Teva Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Teva Pharmaceuticals
-
Table Product and Service Introduction of Teva Pharmaceuticals
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Boehringer Ingelheim GmbH
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim GmbH
-
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim GmbH
-
Figure Revenue and Market Share Analysis of Boehringer Ingelheim GmbH
-
Table Product and Service Introduction of Boehringer Ingelheim GmbH
-
